» Articles » PMID: 38316761

Cellular Senescence of Renal Tubular Epithelial Cells in Acute Kidney Injury

Overview
Date 2024 Feb 5
PMID 38316761
Authors
Affiliations
Soon will be listed here.
Abstract

Cellular senescence represents an irreversible state of cell-cycle arrest during which cells secrete senescence-associated secretory phenotypes, including inflammatory factors and chemokines. Additionally, these cells exhibit an apoptotic resistance phenotype. Cellular senescence serves a pivotal role not only in embryonic development, tissue regeneration, and tumor suppression but also in the pathogenesis of age-related degenerative diseases, malignancies, metabolic diseases, and kidney diseases. The senescence of renal tubular epithelial cells (RTEC) constitutes a critical cellular event in the progression of acute kidney injury (AKI). RTEC senescence inhibits renal regeneration and repair processes and, concurrently, promotes the transition of AKI to chronic kidney disease via the senescence-associated secretory phenotype. The mechanisms underlying cellular senescence are multifaceted and include telomere shortening or damage, DNA damage, mitochondrial autophagy deficiency, cellular metabolic disorders, endoplasmic reticulum stress, and epigenetic regulation. Strategies aimed at inhibiting RTEC senescence, targeting the clearance of senescent RTEC, or promoting the apoptosis of senescent RTEC hold promise for enhancing the renal prognosis of AKI. This review primarily focuses on the characteristics and mechanisms of RTEC senescence, and the impact of intervening RTEC senescence on the prognosis of AKI, aiming to provide a foundation for understanding the pathogenesis and providing potentially effective approaches for AKI treatment.

Citing Articles

The Potential Role of Advanced Glycation End Products in the Development of Kidney Disease.

Ma Y, Wang X, Lin S, King L, Liu L Nutrients. 2025; 17(5).

PMID: 40077627 PMC: 11902189. DOI: 10.3390/nu17050758.


An adoptive cell therapy with TREM2-overexpressing macrophages mitigates the transition from acute kidney injury to chronic kidney disease.

Zhang Y, Liu Y, Luo S, Liang H, Guo C, Du Y Clin Transl Med. 2025; 15(3):e70252.

PMID: 40000418 PMC: 11859120. DOI: 10.1002/ctm2.70252.


Ankrd1 as a potential biomarker for the transition from acute kidney injury to chronic kidney disease.

Li H, Hu L, Zheng C, Kong Y, Liang M, Li Q Sci Rep. 2025; 15(1):4659.

PMID: 39920300 PMC: 11806044. DOI: 10.1038/s41598-025-88752-4.


Human proximal tubular epithelial cell interleukin-1 receptor signalling triggers G2/M arrest and cellular senescence during hypoxic kidney injury.

Giuliani K, Nag P, Adams B, Wang X, Hong S, Grivei A Cell Death Dis. 2025; 16(1):61.

PMID: 39890773 PMC: 11785723. DOI: 10.1038/s41419-025-07386-6.


Xanthohumol attenuates TXNIP-mediated renal tubular injury in vitro and in vivo diabetic models.

Zhang Y, Pan R, Shou Z, Zhao Y J Nat Med. 2025; 79(2):314-327.

PMID: 39752106 DOI: 10.1007/s11418-024-01863-6.


References
1.
Miwa S, Jow H, Baty K, Johnson A, Czapiewski R, Saretzki G . Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice. Nat Commun. 2014; 5:3837. PMC: 4024759. DOI: 10.1038/ncomms4837. View

2.
Yuan Y, Zheng Y, Zhang X, Chen Y, Wu X, Wu J . BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2. Autophagy. 2017; 13(10):1754-1766. PMC: 5640199. DOI: 10.1080/15548627.2017.1357792. View

3.
Jin H, Zhang Y, Ding Q, Wang S, Rastogi P, Dai D . Epithelial innate immunity mediates tubular cell senescence after kidney injury. JCI Insight. 2019; 4(2). PMC: 6413792. DOI: 10.1172/jci.insight.125490. View

4.
Strzyz P . Bend it like glycocalyx. Nat Rev Mol Cell Biol. 2019; 20(7):388. DOI: 10.1038/s41580-019-0142-2. View

5.
Liu J, Yang J, Chen X, Cai G, Lin L, He Y . Impact of ER stress-regulated ATF4/p16 signaling on the premature senescence of renal tubular epithelial cells in diabetic nephropathy. Am J Physiol Cell Physiol. 2015; 308(8):C621-30. DOI: 10.1152/ajpcell.00096.2014. View